Indications for ADVAIR DISKUS 250/50 for COPD
- ADVAIR DISKUS 250/50 is indicated for the twice-daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. ADVAIR DISKUS 250/50 is also indicated to reduce exacerbations of COPD in patients with a history of exacerbations.
- ADVAIR DISKUS 250/50 twice daily is the only approved dosage for the treatment of COPD because an efficacy advantage of the higher strength ADVAIR DISKUS 500/50 over ADVAIR DISKUS 250/50 has not been demonstrated.
- ADVAIR DISKUS is NOT indicated for the relief of acute bronchospasm.
An ICS/LABA (inhaled corticosteroid/long-acting beta2-agonist) for the maintenance treatment of COPD (Chronic Obstructive Pulmonary Disease) including chronic bronchitis and/or emphysema.